Alina Pszczółkowska is holding a position of the Head of Study Management Late-Phase Development in Respiratory&Infection and CVRM (Cardivascular Renal Metabolic) areas, supporting AstraZeneca clinical operations worldwide. Being a physician, she has been involved in managing and leading clinical research projects for more than 20 years. Her international experience includes the leadership of AstraZeneca Site Management and Monitoring organization in 40 countries across the globe as well as 2 years spent in AZ core science site in Gothenburg, where she led program level operational management of cardiovascular portfolio. She has also had a pleasure to play one of key roles in shaping and transforming AstraZeneca’s global Clinical Trials Centre in Warsaw to become the largest and truly unique centre of this kind among all innovative pharmaceutical companies in the country, currently employing more than 1000 people in R&D function. For over 20 years Alina has been supporting and initiating activities in the area of CSR as well as inclusiveness and diversity , which is her true passion.
